# Cisatracurium Besylate

NDC: 83634-655
Generic name: cisatracurium besylate
Labeler / Manufacturer: Avenacy, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260815

FDA application: ANDA216539

## Active ingredients

- CISATRACURIUM BESYLATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83634-655"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83634-655
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c6a8b98-deac-4e25-b4a0-5d0af5090281